Fosun Pharma To Buy Gland Pharma for Up to $1.26 BillionBloomberg News
Deal to be the biggest Indian asset purchase by a Chinese firm
Share trading to be resumed on Friday after one-day halt
Shanghai Fosun Pharmaceutical Group Co. plans to buy Indian drugmaker Gland Pharma Ltd. for no more than $1.26 billion.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.